Vertex Pharmaceuticals discovers, develops and commercializes pharmaceutical products for treatment of cystic fibrosis, cancer, inflammatory bowel, autoimmune disease and neurological disorders. Vertex’s product Trikafta was approved by the USFDA in 2019 for treatment of cystic fibrosis. Other approved cystic fibrosis medicines from Vertex include Symdeko, Orkambi and Kalydeco.
Vertex and CRISPR Therapeutics are collaborating with their treatment, CTX001, made from a patient’s own stem cells harvested and edited using CRISPR technology to increase fetal hemoglobin levels to treat transfusion-dependent beta thalassemia and sickle cell disease.
Timeline
People
Adriana Kwiatkowski
Employee
Adrija Ashrita
Employee
Alison Welch
Employee
Allan Powe
Employee
Andreas Kateifides
Employee
Andrei Jerkovich
Employee
Andrew Berkowitz
Employee
Andrew Cosgrove
Employee
Ankita Deshpande
Employee
Arash Shirazi
Employee
Bob Stack
Employee
Bradford Kellogg
Employee
Brett Busch, Ph.D.
Employee
Carlo Bocconcelli
Employee
Chandra Burra
Employee
Chelsea Lombardi
Employee
Chelsey Jensen
Employee
Chong Lee
Employee
Chris Hughes
Employee
Christina Han
Employee
Corey Gray
Employee
Courtney Bradford
Employee
David Howe
Employee
Dr Janet Fernihough MBA
Employee
Edward Ramos
Employee
Further reading
Documentaries, videos and podcasts
Companies
News
References
Company attributes
Other attributes
Categories
Related Topics
Contributors
- 1
Carla Faraguna
Golden People and Operations. - 2
Meredith Hanel
Medical Genetics PhD, following life science applications that improve the health of humans and our planet. - 3
Joshua Elkington
Axial - 4
Baye Maniago
Passionate about disruptive technology, continuous learning, and personal development - 5
Melanie Manipula
Helping organize knowledge.
